Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck presents imidazole-based cannabinoid CB1 antagonists with utility in obesity

March 10, 2003

Central role identified for ghrelin in energy homeostasis

March 10, 2003

Mechanisms underlying effects of zoledronic acid on prostate cancer bone metastases

March 7, 2003

Dr. Reddy's describes novel antidiabetic agents

March 7, 2003

Series of melanocortin MC4 receptor agonists in early development at Merck

March 7, 2003

BioSante completes menopause phase II/III trial of Bio-E-Gel

March 6, 2003

Consistent positive weight loss trends observed in AOD-9604 trial

March 6, 2003

Reduced hyperinflammatory response reported after postinjury PolyHeme rescue

March 6, 2003

Mercian claims HMG-CoA-inhibitory mevastatin analogues

March 6, 2003

New inhibitors of SGLT transporters discovered by Kyowa Hakko scientists

March 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...